Setrobuvir
Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp.
Product Specifications
CAS Number
1071517-39-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
560.62
Molecular Formula
C25H25FN4O6S2
Notes
Research use only, not for human use.
Receptor
SARS-CoV | DNA/RNA Synthesis | HCV Protease
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog